Submitted for Publication: May 19, 2011; final revision received November 1, 2011; accepted November 4, 2011.
Published Online: January 9, 2012. doi:10.1001/archopthalmol.2011.1921
Author Contributions: Dr Rein and Mr Wittenborn had full access to all simulation data and take responsibility for the integrity of the data and the accuracy of the data analysis. Ms Lee had access to the primary data related to visual status at different cataract levels and takes responsibility for the integrity of the data.
Financial Disclosure: None reported.
Funding/Support: This study was funded by the Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia (contract 200-2008-27958), by the National Eye Institute (awards R21 EY019173 and U10 EY006594-21A1 to Drs B. E. K. Klein and R. Klein), and through a Senior Scientific Investigator Award from Research to Prevent Blindness (to Drs B. E. K. Klein and R. Klein).
Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the official position of the Centers for Disease Control and Prevention or the official views of the National Eye Institute or the National Institutes of Health.
Additional Information: Ms Lee estimated the information included in Table 1 from primary data.